Causal impact of DNA methylation on refracture in elderly individuals with osteoporosis – a prospective cohort study
-
Published:2024-06-03
Issue:1
Volume:25
Page:
-
ISSN:1471-2474
-
Container-title:BMC Musculoskeletal Disorders
-
language:en
-
Short-container-title:BMC Musculoskelet Disord
Author:
Wen Bingtao,Zhang Yaning,He Jianhua,Tan Lei,Xiao Guanggui,Wang Zunliang,Cui Wei,Wu Bingxuan,Wang Xianhai,He Lei,Li Ming,Zhu Zhongjiao,Sang Dacheng,Zeng Changqing,Jia Peilin,Liu Fan,Liu Tianzi
Abstract
Abstract
Background
Osteoporotic vertebral compression fractures (OVCF) in the elderly increase refracture risk post-surgery, leading to higher mortality rates. Genome-wide association studies (GWAS) have identified susceptibility genes for osteoporosis, but the phenotypic variance explained by these genes has been limited, indicating the need to explore additional causal factors. Epigenetic modifications, such as DNA methylation, may influence osteoporosis and refracture risk. However, prospective cohorts for assessing epigenetic alterations in Chinese elderly patients are lacking. Here, we propose to conduct a prospective cohort study to investigate the causal network of DNA polymorphisms, DNA methylation, and environmental factors on the development of osteoporosis and the risk of refracture.
Methods
We will collect vertebral and peripheral blood from 500 elderly OVCF patients undergoing surgery, extract DNA, and generate whole genome genotype data and DNA methylation data. Observation indicators will be collected and combined with one-year follow-up data. A healthy control group will be selected from a natural population cohort. Epigenome-wide association studies (EWAS) of osteoporosis and bone mineral density will be conducted. Differential methylation analysis will compare candidate gene methylation patterns in patients with and without refracture. Multi-omics prediction models using genetic variants and DNA methylation sites will be built to predict OVCF risk.
Discussion
This study will be the first large-scale population-based study of osteoporosis and bone mineral density phenotypes based on genome-wide data, multi-time point methylation data, and phenotype data. By analyzing methylation changes related to osteoporosis and bone mineral density in OVCF patients, the study will explore the feasibility of DNA methylation in evaluating postoperative osteoporosis intervention effects. The findings may identify new molecular markers for effective anti-osteoporosis treatment and inform individualized prevention and treatment strategies.
Trial registration
chictr.org.cn ChiCTR2200065316, 02/11/2022.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2011;6:59–155. 2. Wang O, Hu Y, Gong S, Xue Q, Deng Z, Wang L, Liu H, Tang H, Guo X, Chen J, et al. A survey of outcomes and management of patients post fragility fractures in China. Osteoporos Int. 2015;26(11):2631–40. 3. Feng F, Zhong X, Luo L, Shang C, Huang L, Cheng Z. Clinical observation of percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fracture. J Pak Med Assoc. 2020;70 [Special Issue](9):84–7. 4. Lu L, Liu Y, Nazierhan S, Sun Z, Aikeremu D, Alimasi W, Xu K, Niyazi W, Wang H. Expression changes of IL-17 in zoledronic acid combined with PVP technology in the treatment of postmenopausal osteoporotic vertebral compression fracture and its predictive value of relapse. J Musculoskelet Neuronal Interact. 2020;20(4):563–9. 5. Ma X, Xing D, Ma J, Wang J, Chen Y, Xu W, Yang Y, Ma B, Zhu S. Risk factors for new vertebral compression fractures after percutaneous vertebroplasty: qualitative evidence synthesized from a systematic review. Spine (Phila Pa 1976). 2013;38(12):E713-722.
|
|